SLC44A4 Antibody (ASG-5ME) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28624PCP
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Flow Cytometry, Functional
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Recombinant Monoclonal Human IgG2 Clone # ASG-5ME
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for SLC44A4 Antibody (ASG-5ME) [PerCP]
Immunogen
SLC44A4
Clonality
Monoclonal
Host
Human
Isotype
IgG2
Applications for SLC44A4 Antibody (ASG-5ME) [PerCP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SLC44A4
Alternate Names
C6orf29, Choline Transporter-Like Protein 4, Chromosome 6 Open Reading Frame 29, CTL4, NG22, Solute Carrier Family 44 Member 4, Solute Carrier Family 44, Member 4
Gene Symbol
SLC44A4
Additional SLC44A4 Products
Product Documents for SLC44A4 Antibody (ASG-5ME) [PerCP]
Product Specific Notices for SLC44A4 Antibody (ASG-5ME) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...